Alexander Yur'evich Mayorov

Author

Also Known As

A Mayorov, A Yu Mayorov, A. Bronisz, A. Mayorov, A. V. Mayorov, A. Y. Mayorov, A. Yu Mayorov, A. Yu. Mayorov, A.Yu. Mayorov, ALEXANDR MAYOROV

173

Publications

Citations

H-Index

112

Concepts

All Affiliations

University of Arizona Endocrinology Research Center Scripps Research Institute Sechenov University National Institutes of Health

About

Alexander Yur'evich Mayorov is an author at University of Arizona specializing in medicine, pharmacology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	29	2.7K
2	Health Sciences	7	8	245
3	Natural Sciences	5	5	95
4	Nursing	2	2	63
5	Education	1	1	13

Alexander Yur'evich Mayorov

Publications

4.2K

Citations

H-Index

Page 1

	Year	Citations
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans Jeffrey S. Mogil, Sonya G. Wilson, Elissa J. Chesler, Proceedings of the National Academy of Sciences	2003	517
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings David C. Klonoff, Jing Wang, David Rodbard, Journal of Diabetes Science and Technology	2022	254
Diabetes Attitudes, Wishes and Needs second study (DAWN2™): Cross‐national comparisons on barriers and resources for optimal care—healthcare professional perspective Richard I. G. Holt, Antonio Nicolucci, Katharina Kovacs Burns, Diabetic Medicine	2013	166
A Vaccine Strategy that Induces Protective Immunity against Heroin G. Neil Stowe, Leandro F. Vendruscolo, Scott Edwards, Journal of Medicinal Chemistry Vaccine StrategyImmunologyImmunotherapeuticsImmune SystemSynthetic Immunology	2011	115
Biological and conformational study of β‐substituted prolines in MT‐II template: steric effects leading to human MC5 receptor selectivity* Minying Cai, C. Cai, Alexander Yur'evich Mayorov, Journal of Peptide Research	2004	88
Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs Gary R. Matyas, Alexander Yur'evich Mayorov, Kenner C. Rice, Vaccine Drug TargetDrug TargetingMedicineImmunologyPharmacotherapy	2013	80
Impact of Distinct Chemical Structures for the Development of a Methamphetamine Vaccine Amira Y. Moreno, Alexander Yur'evich Mayorov, Kim D. Janda Journal of the American Chemical Society	2011	79
Efficacy, but Not Antibody Titer or Affinity, of a Heroin Hapten Conjugate Vaccine Correlates with Increasing Hapten Densities on Tetanus Toxoid, but Not on CRM<sub>197</sub>Carriers Rashmi Jalah, Oscar B. Torres, Alexander Yur'evich Mayorov, Bioconjugate Chemistry Antibody TiterDrug TargetImmunologyImmunodominancePharmacotherapy	2015	69
Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease М. V. Maevskaya, Yu. V. Kotovskaya, N. I. Gheivandova, Russian Journal of Gastroenterology Hepatology Coloproctology Non-alcoholic Liver DiseaseLiver FibrosisGastroenterologyPathologyClinical Guidelines	2022	65

Page 1